- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/35 - Corticotropin [ACTH]
Patent holdings for IPC class A61K 38/35
Total number of patents in this class: 73
10-year publication summary
|
5
|
7
|
2
|
7
|
8
|
3
|
10
|
2
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
7 |
| Mallinckrodt ARD IP Limited | 8 |
6 |
| AC Pharmaceuticals Co., Ltd. | 22 |
4 |
| Health Ricerca e Sviluppo S.R.L. | 3 |
3 |
| Harrow IP, LLC | 211 |
3 |
| Mallinckrodt ARD IP Unlimited Company | 4 |
3 |
| Adamis Pharmaceuticals Corporation | 35 |
2 |
| Intarcia Therapeutics, Inc. | 103 |
2 |
| Ipsen Pharma S.A.S. | 387 |
2 |
| Nanyang Technological University | 1903 |
2 |
| Questcor Pharmaceuticals, Inc. | 5 |
2 |
| Regeneron Pharmaceuticals, Inc. | 4019 |
2 |
| Rhythm Pharmaceuticals, Inc. | 62 |
2 |
| Zhang Jing | 92 |
2 |
| Acthar IP | 2 |
2 |
| National Skin Center (S) Pte Ltd | 3 |
2 |
| Nanjing Hanxin Pharmaceutical Technology Co. Ltd | 19 |
2 |
| Amzell B.V. | 3 |
2 |
| Unilever PLC | 3313 |
1 |
| Unilever N.V. | 3209 |
1 |
| Other owners | 21 |